JHTV Mentors-In-Residence (MIRs) operate under nondisclosure agreements and share their business and technical expertise with FastForward startups.
James Campbell, M.D., seeks new opportunities to invest in innovative technologies in the areas of therapeutics and devices, and he works with entrepreneurs at the early stages of company formation.
Arthur (Skip) Colvin
Arthur (Skip) Colvin is a senior technical executive and serial entrepreneur with a consistent 35+ year record of technical innovation and successful leadership of entrepreneurial product creation and development programs.
Graham Dodge is the founding CEO of Sickweather, a disease prediction company that reaches an audience of over 10 million daily active users and powers an estimated $320 million in digital health care advertising.
AJ Donelson is a Johns Hopkins alumnus who has been mentoring JHU start-ups and researchers since 2015. Donelson also serves on the review committee for the Cohen Translational Engineering Fund.
Richard (Ric) Hughen
Richard (Ric) Hughen’s 30 years of professional experience in the life science industry span three startups, a mid-cap and three Fortune 500 companies. He is currently CEO of Cellth Systems, a startup based upon proprietary Circulating Tumor Cell (CTC) analysis technology.
Bill McNamara is President of EcoEnergy LLC, a renewable energy consulting and project development company in Old Lyme, Ct. EcoEnergy serves utility and commercial clients, and develops privately financed solar and energy storage projects in the North East US.
Joseph M. Migliara
Joseph M. Migliara is a senior level biomedical executive and proven builder of successful fast-growth businesses. He is an experienced CEO and group president of a multinational operating division.
Dr. Miller has been the founder and/or or CEO of 4 biotechnology companies and is an adjunct faculty member at the Johns Hopkins School of Medicine.
Caroline Popper founded Popper and Company with Ken Walz more than 15 years ago to address inefficiencies in health care by helping life science companies develop and commercialize new technology.
Michael Richman is currently, president and CEO of NextCure, a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Daniel J. Roche
For more than 25 years, Daniel J. Roche as advised business and government on the strategic use of technology to improve the value and service of their organizations.
Sean R. Tunis
Sean Tunis, MD, MSc. is the founder and senior strategic advisor with the Center for Medical Technology Policy in Baltimore.